Critical study of 5% guanethidine in ocular manifestations of Graves's disease
- 13 December 1969
- Vol. 4 (5684), 645-647
- https://doi.org/10.1136/bmj.4.5684.645
Abstract
Assessment was made of 5% local guanethidine in treating eye manifestations in euthyroid patients with either treated thyrotoxicosis or ophthalmic Graves's disease. In a double-blind crossover study guanethidine caused greater improvement in lid retraction than a control solution. A long-term study showed that this improvement was maintained. A much lower incidence of side-effects was noted with 5% guanethidine than with 10% solution.Keywords
This publication has 6 references indexed in Scilit:
- Treatment of dysthyroid ophthalmopathy with local guanethidine.British Journal of Ophthalmology, 1969
- Dysthyroid eye disease. A trial of guanethidine eye drops.British Journal of Ophthalmology, 1969
- Unwanted pharmacological effects of local guanethidine in the treatment of dysthyroid upper lid retraction.British Journal of Ophthalmology, 1969
- Ophthalmic Graves' disease--clinical and laboratory features.1968
- Long-term trial of local guanethidine in treatment of eye signs of thyroid dysfunction and idiopathic lid retraction.BMJ, 1967
- ADRENERGIC BLOCKADE AND THE EYE SIGNS OF THYROTOXICOSISThe Lancet, 1966